Skip to content
Tirzepatide Report
Provider review

NowPatient Tirzepatide Review: Mounjaro Prices & Country Limits

Published by Tirzepatide ReportUpdated

On this page

Mounjaro KwikPen pricing with country, shipping and import conditions to confirm.

Standout details

  • Named Mounjaro product and dose-specific public price table
  • Consultation advertised free

Things to consider

  • US dispensing/import pathway not established by the page
  • Free delivery depends on Core+ Plan

NowPatient’s Mounjaro page displayed $251.98 for one 2.5 mg KwikPen, plus $75 labeled shipping and import duties: $326.98 total if approved on October 25, 2026. Its price table separately labels delivery $0 with a Core+ Plan. Those displays describe different conditions; neither establishes a universal monthly total or free delivery for every order.3

There is also a country distinction. The page displayed US-dollar pricing but describes Mounjaro’s UK weight-management authorization and identifies UK pharmacy services in its footer. A dollar sign or a US office address does not verify a domestic US prescription, dispensing or importation pathway. Confirm which service, jurisdiction and product apply before using this as a US treatment quote.3,4

The named product and consultation

The reviewed offer is Lilly-branded Mounjaro in a KwikPen presentation. The page advertises a free private prescription and face-to-face video consultation with a prescribing pharmacist, nurse or doctor, subject to approval. It says the clinician recommends strength and quantity. That is a description of the public offer, not a completed clinical assessment or guarantee you will receive treatment.3

The page’s drug information uses UK approval language for weight loss. This review does not transfer that indication or the displayed presentation to US FDA-approved use, nor establish that this specific supply is an FDA-approved US product. The brand-access comparison addresses other routes separately. A domestic Zepbound offer and this Mounjaro display should not be treated as interchangeable transactions.

Observed product and delivery display

ItemPublished terms
Selected starting strength2.5 mg/0.5 mL; one KwikPen
Medication display$251.98
Shipping and import duties$75; selected total $326.98 if approved
Table delivery$0 only with Core+ Plan condition
Observed product and delivery display

How to read the price and delivery table

The selected starting-strength display was $326.98 including the separately labeled $75 charge. The medication table also lists $287.98 at 5 mg, $377.98 at 7.5 mg, $413.98 at 10 mg, $458.98 at 12.5 mg and $476.98 at 15 mg, each for a quantity of one KwikPen. These are product-price observations, not a dose recommendation or proof of what a clinician would prescribe.3

The table’s $0 delivery entries are expressly conditional on the Core+ Plan. Its cost and applicability were not established by that table alone. Do not remove the $75 from the selected display, assume the plan is free, or multiply a pen price into a monthly or annual treatment total without confirming the supplied quantity, device and billing arrangement. Ask for the full charge on the exact route you are eligible to use.

Delivery is advertised within 7–10 working days if approved. That estimate is not proof of stock, a guaranteed arrival date or authorization to ship to every US state. Cross-border charges and the applicable dispensing arrangement should be confirmed separately from clinical approval. The presence of multiple currencies and regional services makes a country-specific written explanation especially useful.3,4

Cancellation terms have limited scope

NowPatient’s general Terms, updated October 16, 2026, are operated by Infohealth Limited and contain distinct sections for general services, NHS repeat prescriptions and other product purchases. The dedicated cancellation page discusses European consumer rules and a UK return address. These provisions do not establish a blanket US Mounjaro refund promise.4,5

The NHS section permits cancellation before dispensing, while its separate product-return section describes a 14-working-day period and restrictions on opened, damaged or unsealed goods. Do not apply either provision indiscriminately to an imported prescription product. Ask which financial terms govern your specific order, including what happens if no prescription is issued, shipping is delayed or the product cannot be supplied.4,5

Confirm the applicable transaction

ItemPublished terms
Country and productUK authorization wording does not verify a US product route
ConsultationAdvertised free; treatment requires approval
Arrival estimate7–10 working days if approved
Refund conditionsGeneral/UK/NHS policy scopes must be distinguished
Confirm the applicable transaction

A free consultation does not resolve every later financial question. Nor does an appointment or prescription establish approval for a particular destination. Keep the provider, pharmacy, country, quantity, delivery charge and cancellation deadline together when comparing the offer with another service.

Clinical claims remain separate

A provider’s price table and approval wording cannot substitute for appropriate clinical care or product-specific instructions. Some informational material on the page discusses different regulatory settings, so confirm the actual supplied device and instructions with your clinician or pharmacist. This review does not repeat its dosing or missed-dose directions. Discuss Zepbound side effects, the gallbladder risk, and the thyroid cancer warning using the information applicable to your prescribed product.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

Comparing a confirmed route

NowPatient publishes a named product and price schedule, but country, delivery and contract conditions remain essential to interpretation. NewSelf, the brand-access roundup and PrideRx describe different products or services; their permissions and refund terms do not transfer here. Use the provider comparison after confirming the complete arrangement rather than choosing on the lowest displayed currency figure.

Frequently asked questions

Is Mounjaro $1,069 monthly through NowPatient?

That older figure was not reconfirmed. The selected display was $251.98 plus $75 shipping/import duties for one starting-strength KwikPen, if approved.3

Is delivery free?

The table says $0 with a Core+ Plan; the selected product display adds $75. Confirm plan eligibility, cost and the final total.3

Does the page verify a US FDA-approved dispensing route?

No. US-dollar pricing and a US office do not verify the product and jurisdiction applicable to a particular patient. The page also uses UK authorization language.3,4

Does its 14-day return wording guarantee a medication refund?

No. The policies contain different general, UK consumer and NHS scopes. Obtain the terms for the specific prescription order rather than transferring a general return rule.4,5

References(5)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. NowPatient (2026). Mounjaro product, selected US-dollar display and price table. NowPatient.
  4. NowPatient (2026). Terms of use, updated October 16, 2026. NowPatient.
  5. NowPatient (2026). Cancellation and returns. NowPatient.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.